Loss of expression of reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 expression in gastric cancer

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Saavedra, Kathleen ^a,b   Valbuena, José ^a   Olivares, Wilda ^a   Marchant, María José ^c   Rodríguez, Andrés ^a   Torres Estay, Verónica ^a   Carrasco Avino, Gonzalo ^d,e   Guzmán, Leda ^c   Aguayo, Francisco ^f   Roa, Juan Carlos ^a   Corvalán, Alejandro H ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P73; PROTEIN REPRIMO; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; GLYCOPROTEIN; NUCLEAR PROTEIN; P73 PROTEIN, HUMAN; RPRM PROTEIN, HUMAN; TUMOR PROTEIN P73; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; STOMACH CANCER; TUMOR VOLUME; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DISEASE COURSE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR STEM CELL ASSAY;

CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TUMOR PROTEIN P73; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84941120566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125834     Document Type: Article

References (22)

1. Forman D, Bray F, Brewster DH, Gombe-Mbalawa C, Kohler B, Piñeros M, et al. Cancer Incidence in Five Continents, Vol. X IARC. 2013: Available: http://globocan.iarc.fr.
2. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014; 20: 13842-13862. doi:10.3748/wjg.v20.i38.13842 PMID: 25320521.
3. McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014; 11: 664- 674. doi:10.1038/nrgastro.2014.143 PMID: 25134511.
4. Bass AJ. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513: 202-209. doi:10.1038/nature13480 PMID: 25079317.
5. Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, et al. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene. 2010; 29: 2104- 2117. doi:10.1038/onc.2009.493 PMID: 20154727.
6. Xu M, Knox AJ, Michaelis KA, Kiseljak-Vassiliades K, Kleinschmidt-DeMasters BK, Lillehei KO, et al. Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity. Endocrinology. 2012; 153: 2963-2973. doi:10.1210/en.2011-2021 PMID: 22562171.
7. Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer. 2010; 127: 2588-2597doi:10.1002/ijc.25274PMID: 20178103.
8. Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008; 14: 6264-6269. doi:10.1158/1078-0432.CCR-07-4522 PMID: 18829507.
9. Sapari NS, Loh M, Vaithilingam A, Soong R. Clinical potential of DNA methylation in gastric cancer: A meta-analysis. PLoS One. 2012; 7: e36275. doi:10.1371/journal.pone.0036275PMID: 22558417.
10. Ohki R, Nemoto J, Murasawa H, Oda E, Inazawa J, Tanaka N, et al. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem. 2000; 275: 22627-22630. PMID: 10930422.
11. Luo J, Zhu Y, Yang G, Gong L, Wang B, Liu H. Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma. Diagn Cytopathol. 2010.
12. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14: 101-112. doi:10.1007/s10120-011-0041-5 PMID: 21573743.
13. Llorens P. Gastric cancer mass survey in Chile. Surg Semin Oncol. 1991; 7: 339-343. PMID: 1759081.
14. Carrasco G, Diaz J, Valbuena JR, Ibanez P, Rodriguez P, Araya G, et al. Overexpression of p73 as a tissue marker for high-risk gastritis. Clin Cancer Res. 2010; 16: 3253-3259. doi:10.1158/1078-0432.CCR-09-2491PMID: 20530692.
15. Bernal C, Vargas M, Ossandon F, Santibanez E, Urrutia J, Luengo V, et al. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Biol Res. 2008; 41: 303-315. PMID: 19399343.
16. Inoue H, Nojima H, Okayama H. High efficiency transformation of Escherichia coli with plasmids. Gene. 1990; 96: 23-28. PMID: 2265755.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408. PMID: 11846609.
18. Ooki A, Yamashita K, Yamaguchi K, Mondal A, Nishimiya H, Watanabe M. DNA damage-inducible gene, Reprimo functions as a tumor-suppressor and is suppressed by promoter methylation in gastric cancer. Mol Cancer Res. 2013; 11: 1362-1374. doi:10.1158/1541-7786.MCR-13-0091 PMID: 23982217.
19. Vanlandingham JW, Tassabehji NM, Somers RC, Levenson CW. Expression profiling of p53-target genes in copper-mediated neuronal apoptosis. Neuromolecular Med. 2005; 7: 311-324. PMID: 16391388.
20. Pflaum J, Schlosser S, Muller M. p53 Family and Cellular Stress Responses in Cancer. Front Oncol. 2014; 4: 285. doi:10.3389/fonc.2014.00285 PMID: 25374842.
21. Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 1998; 9: 897-903. PMID: 9831242.
22. Marabese M, Vikhanskaya F, Broggini M. p73: A chiaroscuro gene in cancer. Eur J Cancer. 2007; 43: 1361-1372. PMID: 17428654.